<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    LoveBug Nutrition Inc.

    LoveBug Nutrition Inc.

    LoveBug Probiotics brings customers an award-winning range of probiotic supplement...

    LoveBug Probiotics brings customers an award-wi...

    Amount Raised:    $448,074.24
    Fundraising Status:    EC
    Filing Type:    CF

    111, Inc.

    111,Inc., co-founded by Gang Yu and Junling Liu in 2010, is a leading digital and ...

    111,Inc., co-founded by Gang Yu and Junling Liu...

    Filing Type:    PU
    Allogene Therapeutics, Inc.

    Allogene Therapeutics, Inc.

    Allogene Therapeutics is a clinical stage biotechnology company pioneering the dev...

    Allogene Therapeutics is a clinical stage biote...

    Filing Type:    PU
    Rexahn Pharmaceuticals, Inc.

    Rexahn Pharmaceuticals, Inc.

    Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to ...

    Rexahn Pharmaceuticals is a clinical stage biop...

    Filing Type:    PU
    Supernus Pharmaceuticals, Inc.

    Supernus Pharmaceuticals, Inc.

    Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing a...

    Supernus Pharmaceuticals, Inc. is a pharmaceuti...

    Filing Type:    PU
    Dicerna Pharmaceuticals, Inc.

    Dicerna Pharmaceuticals, Inc.

    Dicerna is a biopharmaceutical company focused on the discovery and development of...

    Dicerna is a biopharmaceutical company focused ...

    Filing Type:    PU

    Predictive Oncology Inc.

    Predictive Oncology is a clinical and translational data pipeline and AI-driven pl...

    Predictive Oncology is a clinical and translati...

    Filing Type:    PU
    Nymox Pharmaceutical Corporation

    Nymox Pharmaceutical Corporation

    Nymox Pharmaceutical Corporation specializes in the research and development of th...

    Nymox Pharmaceutical Corporation specializes in...

    Filing Type:    PU
    BioXcel Therapeutics, Inc.

    BioXcel Therapeutics, Inc.

    BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused o...

    BioXcel Therapeutics, Inc. is a clinical stage ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.